---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076884"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:37:44.532242+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Renalytix receives Nasdaq delisting notice; intends to appeal by June 28

## Summary
- Nasdaq determined company did not regain compliance with minimum bid price ($1.00) and MVLS ($50M) by June 19, 2024.
- Unless appeal is filed by June 28, ADS trading will be suspended at opening on July 2, 2024, and Form 25-NSE filed.
- Company intends to request a hearing before Nasdaq Hearings Panel, which will stay suspension pending decision.
- Plan to present a strategic plan to regain compliance; no assurance of acceptance or success.
- Delisting could impair liquidity, accurate quotations, and ability to raise capital.

## SEC filing metadata
- accession: 0000950170-24-076884
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024076884/0000950170-24-076884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024076884/rnlx-20240621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076884
- JSON: https://secwatch.observer/filing/0000950170-24-076884.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076884.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.